drugset / Trial / NCT02291263
Immunogenicity of Intramuscular Inactivated Poliovirus Vaccine
Phase 3
Completed
738 enrolled
Centers for Disease Control and Prevention
International Centre for Diarrhoeal Disease Research, Bangladesh · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
This study will be an open-label phase III randomized clinical trial comparing different combinations and regimens of polio vaccines. The trial will compare one and two doses of IPV administered at 6 weeks or 14 weeks or 6 and 14 weeks of age. All participants will also receive bOPV at 6, 10 and 14 weeks of age.
Timeline
- Start
- 2014-10
- Primary completion
- 2015-07
- Completion
- 2015-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | IPV | Vaccine | — | Intramuscular |
| Comparator | bivalent OPV | Vaccine | — | Oral |